Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
Following publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below.
Main Authors: | Thomas G. de Leeuw, Laura Mangiarini, Rebecca Lundin, Florentia Kaguelidou, Tjitske van der Zanden, Oscar Della Pasqua, Dick Tibboel, Adriana Ceci, Saskia N. de Wildt, on behalf of the GAPP consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Trials |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3519-9 |
Similar Items
-
Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
by: Thomas G. de Leeuw, et al.
Published: (2019-01-01) -
Diagnosis and Treatment of Chronic Neuropathic and Mixed Pain in Children and Adolescents: Results of a Survey Study amongst Practitioners
by: Thomas G. de Leeuw, et al.
Published: (2020-11-01) -
Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain
by: Paul Healy, et al.
Published: (2023-10-01) -
Gabapentin for chronic neuropathic pain in adults
by: Wiffen, P, et al.
Published: (2009) -
Gabapentin for presumed neuropathic ocular pain
by: Raman Michael, et al.
Published: (2020-09-01)